SUPRACHOROIDAL INTERNAL DEVELOPMENT PIPELINE

STUDY DRUG

INDICATION

CURRENT STATUS

STUDY DRUG, INDICATION, CURRENT STATUS

CLS-AX
(axitinib injectable suspension)

Wet AMD

Integrin Inhibitor
(Injectable suspension)

Diabetic Macular Edema (DME)

Gene Therapy

“Therapeutic Biofactory” /
Inherited Retinal Disease

COMMERCIAL COLLABORATIONS

PARTNER

LICENSED TERRITORY

CURRENT STATUS

PARTNER, INDICATION, CURRENT STATUS

BAUSCH HEALTH

U.S. & Canada

ARCTIC VISION

Greater China, South Korea, ASEAN Countries, India, Australia, New Zealand

DEVELOPMENT AND COMMERCIAL COLLABORATIONS USING SCS MICROINJECTOR®

PARTNER

LICENSED INDICATION

CURRENT STATUS

PARTNER, INDICATION, CURRENT STATUS

REGENXBIO

Wet AMD (AAVIATE)

REGENXBIO

Diabetic Retinopathy (ALTITUDE)

AURA BIOSCIENCES

Ocular Oncology / Choroidal Melanoma